Stay updated with breaking news from Gavin Cloherty. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
End-of-treatment data from two Phase 2a combination clinical trials with imdusiran to be presented at the EASL Congress in June 2024 Preliminary data from the single-dose portion of the AB-101-001...
Imdusiran data will be highlighted in late breaking presentation WARMINSTER, Pa., Oct. 11, 2023 -- Arbutus Biopharma Corporation , a clinical-stage biopharmaceutical company leveraging its...
Abbott is joining the Climate Amplified Disease and Epidemics (CLIMADE) consortium, which will use data science to predict, track and control diseases that are being amplified by climate change
Crain's Health Pulse is your source for actionable, exclusive and inside news on the health care industry.
Abbott and New Global Consortium Partnership Address Viral Outbreaks ...